-
-
SAFESTEREO
-
-
SAFESTEREO
-
-
Patient and physician shared decision-making behaviors in oncology
-
-
Treatment strategies for metastatic soft tissue sarcomas
-
-
Systematic review of clinical practice guidelines for colorectal and anal cancer: the extent of recommendations for managing long-term symptoms and functional impairments
-
-
Postoperative Pelvic Radiotherapy in Patients With Endometrial Cancer May Increase the Risk for Secondary Pelvic Cancers: A Post Hoc Analysis of Results From the TME, PORTEC-1, and PORTEC-2 Trials Reply
-
-
Long-term effects and quality of life after treatment for rectal cancer
-
-
Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy
-
-
Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy
-
-
A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial
-
-
Bowel Function 14 Years After Preoperative Short-Course Radiotherapy and Total Mesorectal Excision for Rectal Cancer: Report of a Multicenter Randomized Trial
-
-
No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials
-
-
No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
-
-
No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
-
-
Second cancers in patients treatred with surgery and radation therapy for rectal or endometrical cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials
-
-
Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomised trial
-
-
Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
-
-
Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial
-
-
Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial
-
-
Health-related quality of life of patients 14 years after short-term preoperative radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomized trial
-
-
Bowel function 14 years after sphincter-preserving total mesorectal excision for rectal cancer: Report of a multicentre randomised trial
